John Marioni (via Wellcome Sanger Institute)
April 28, 2022 08:30 AM EDTUpdated May 2, 04:31 PM
Bioregnum
Pharma

Aviv Regev re­cruits a ‘pur­ple uni­corn’ for the top post in the com­pu­ta­tion­al pil­lar she’s build­ing at Genen­tech

Two years af­ter Aviv Regev left her sci­en­tif­ic abode at the Broad and jour­neyed west to take over as the new head of re­search and …

Endpoints Premium

This article is available only to Premium subscribers

Upgrade to Premium for unlimited access and Premium exclusives.

UPGRADE
TRENDING NOW

The End­points 2024 win­ners and losers list: Who was up and who was down in bio­phar­ma

FDA ap­proves Hu­ma­cyte’s lab-grown blood ves­sels in mile­stone for re­gen­er­a­tive med­i­cine

Up­dat­ed: No­vo’s 23% weight loss with Ca­griSe­ma falls short of high ex­pec­ta­tions, new tri­al planned

Califf, on his way out at FDA, pre­dicts agency tug-of-war be­tween Ra­maswamy and RFK Jr.

Ac­cel­er­at­ed ap­proval brings Pfiz­er's BRAF in­hibitor to first-line pa­tients

Ex­clu­sive: Flori­da can­cer biotech rais­es $100M Se­ries A

A service from the Financial Times